Article
DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo
22 Dec 2021
Abstract excerpt
Manipulating lymphocyte functions with gene silencing approaches is promising for treating autoimmunity, inflammation, and cancer. Although oligonucleotide therapy has been proven to be successful in treating several conditions, efficient in vivo delivery of oligonucleotide to lymphocyte populations remains a challenge. Here, we demonstrate that intravenous injection of a heteroduplex oligonucleotide (HDO),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
